Collin joined Foresite Capital in 2016 and is a member of the investment team focusing on due diligence and financial modeling of investment opportunities.
Collin started his career as an investment banking analyst in the Healthcare Group at Bank of America Merrill Lynch, where he focused on biopharma mergers & acquisitions and capital markets transactions.
Collin received a B.S. in Bioengineering with a concentration in Biotechnology from the University of California, San Diego.
